CPGR Using Peptide Arrays to ID Antibodies for Use in Influenza Biomarker Panel | GenomeWeb

This story originally ran on June 24.

By Adam Bonislawski

South Africa's Centre for Proteomic and Genomic Research is developing high-density arrays of synthetic peptides in an effort to identify influenza antibodies that could serve as a biomarker panel for vaccine development.

In a project announced last week, CPGR is collaborating with scientists from the University of British Columbia to build a biomarker signature that could be used in the development of seasonal influenza vaccines.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.